GSK
GSK plc · Healthcare · Drug Manufacturers - General
Momentum inputs (comparable managers):
holder breadth -6.2% ·
share flow +6.0% ·
net new positions -6.7%
— formula
Concentrated accumulation — rising shares among fewer holders
All ownership figures: tracked 13F managers only, common-stock positions, reporting period Q4 2024
| Quarter | Holders | Δ | Shares | Reported value | New | Exits |
|---|---|---|---|---|---|---|
| Q2 2026 | 118 | +2 | 291.90M | $15.17B | +8 | −5 |
| Q1 2026 | 116 | 0 | 315.42M | $17.28B | +8 | −8 |
| Q4 2025 | 115 | +4 | 328.16M | $15.98B | +4 | — |
| Q3 2025 | 18 | -1 | 242.57M | $10.47B | +1 | −3 |
| Q2 2025 | 17 | +1 | 220.73M | $8.48B | +2 | −1 |
| Q1 2025 | 14 | -1 | 157.56M | $6.11B | — | −1 |
| Q4 2024 | 15 | -1 | 135.53M | $4.59B | — | −1 |
| Q3 2024 | 15 | +3 | 120.78M | $4.99B | +3 | — |
| Q2 2024 | 12 | — | 118.47M | $4.56B | — | — |
| # | Manager | Shares | Δ shares | Value | Their weight | Held | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 68.44M | +0.5% | $2.31B | 1.3% | ▲ Add | 3 | SEC ↗ |
| 2 | PRIMECAP Management ✦ | 25.26M | +70.1% | $854.35M | 0.7% | ▲ Add | 3 | SEC ↗ |
| 3 | Fisher Asset Management ✦ | 18.84M | +1.4% | $637.06M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 4 | T. Rowe Price ✦ | 7.57M | +0.5% | $255.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 5 | T. Rowe Price ✦ | 7.57M | +0.5% | $255.91M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 6 | State Street Global Advisors ✦ (passive) | 7.03M | — | $240.32M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | Renaissance Technologies ✦ | 2.76M | +18.0% | $93.18M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 8 | Bridgewater Associates ✦ | 2.25M | +132.7% | $76.02M | 0.3% | ▲ Add | 3 | SEC ↗ |
| 9 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 10 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 11 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 12 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 14 | Wellington Management ✦ | 2.09M | +10.0% | $70.82M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 574.75K | +602.5% | $19.44M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 16 | Arrowstreet Capital ✦ | 218.26K | -94.4% | $7.38M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 17 | Citadel Advisors ✦ | 183.81K | -68.2% | $6.22M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 18 | D. E. Shaw & Co. ✦ | 114.11K | -7.1% | $3.86M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 19 | Tweedy, Browne ✦ | 93.82K | -13.2% | $3.17M | 0.2% | ▼ Trim | 3 | SEC ↗ |
| 20 | Millennium Management ✦ | 91.56K | -93.7% | $3.10M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 21 | AQR Capital Management ✦ | 21.82K | -20.5% | $737,922 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 22 | AQR Capital Management ✦ | 21.82K | -20.5% | $737,922 | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 23 | AQR Capital Management ✦ | 21.82K | -20.5% | $737,922 | 0.0% | ▼ Trim | 3 | SEC ↗ |
“Their weight” = the position's share of that manager's reported 13F equity value — the conviction measure. ✦ = curated manager.
New buyers
| No new tracked buyers this quarter. |
Exited
| Marshall Wace | $11.58M | was 0.0% |
Full-market context: across ALL 13F filers (SEC structured data, Q1 2026): 2 holders, 16.10M shares, $459.30M reported. This is a different, older period than the tracked-universe figures above and the two are never mixed.
What else this security's tracked holders most often hold — shared-ownership counts, not fundamental relationships.